Effect of Single Event Multi Level Chemoneurolysis with AbobotulinumtoxinA (Dysport) on Energy Expenditure and Walking Efficiency in Children with Cerebral Palsy
Effects of Dysport (Botulinum toxin) Injections on Energy Consumption and Walking Efficiency in Children with Cerebral Palsy
Sponsor: Ipsen Pharmaceuticals
Enrolling: Male and Female Patients
Clinic Visits: 4
IRB Number: AAAR1322
U.S. Govt. ID: NCT03469999
Contact: Nancy Lee: 2123059416 / nl2674@columbia.edu
Additional Study Information: This study aims to evaluate the efficacy of single event multi level chemoneurolysis with the a botulinum toxin A drug, Dysport, on walking energy expenditure and gait in children with spastic diplegia Cerebral Palsy.
This study is closed
Investigator
Heakyung Kim, MD
Do You Qualify?
Is your child between the ages of 5 and 17 years old? Yes No
Is your child over 45lbs? Yes No
Is your child able to walk with or without an assistive device? Yes No
Does your child have stiff/spastic legs? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Nancy Lee
nl2674@columbia.edu
2123059416
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE